Aeglea BioTherapeutics, Inc.

Q3 2026 13F Holders

Symbol
SYRE
CUSIP
00773J202
Type
Equity
Class
COM NEW
Num filings
2
Total reported value, excl. options
$172 k
Manager Report Date Value ($000) Shares Option Type